Dr. Reddy’s Laboratories Ltd ADR (RDY)

Dr. Reddy’s Laboratories Ltd ADR (RDY) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $11B; returns 1 day -0.2%, 1 week +1.1%, 1 year -9.6%.

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company headquartered in India, primarily focused on developing, manufacturing, and marketing a diverse portfolio of affordable and innovative medicines worldwide.

Groups RDY belongs to

• Dividend Payers
• 25-Year Dividend Payers
• Pharmaceuticals
• India Companies
• Healthcare
• Generics
• Life Sciences
• Emerging Markets
• Contract Development and Manufacturing Organizations (CDMO)
• Biotechnology
• Oncology

RDY financial model: income statement, cash flow and balance sheet